Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Bristol-Myers Squibb Co., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	12,599)	10,875)	10,346)	7,890)	6,293)	9,330)	11,464)	7,514)	8,372)	8,995)	9,123)	7,734)	10,750)	12,369)	13,979)	13,540)	11,024)	10,982)	14,546)	19,435)	19,934)	15,817)
Marketable debt securities	1,004)	907)	513)	204)	360)	340)	816)	171)	358)	274)	130)	1,293)	2,478)	2,599)	2,987)	2,123)	1,946)	1,948)	1,285)	1,720)	1,724)	2,505)
Receivables	11,415)	10,801)	10,747)	11,026)	11,423)	10,447)	10,921)	10,304)	10,112)	10,054)	9,886)	9,613)	9,054)	8,511)	9,369)	9,245)	9,017)	8,660)	8,501)	8,062)	7,855)	8,290)
Inventories	2,737)	2,666)	2,557)	3,332)	3,077)	2,985)	2,662)	2,436)	2,364)	2,605)	2,339)	2,074)	2,142)	2,104)	2,095)	2,163)	2,137)	1,953)	2,074)	1,949)	2,384)	2,836)
Other current assets	5,467)	5,534)	5,617)	5,623)	5,737)	5,567)	5,907)	7,207)	6,868)	5,158)	5,795)	6,082)	5,762)	4,538)	4,832)	4,372)	5,037)	3,568)	3,786)	3,111)	2,446)	2,405)
Current assets	33,222)	30,783)	29,780)	28,075)	26,890)	28,669)	31,770)	27,632)	28,074)	27,086)	27,273)	26,796)	30,186)	30,121)	33,262)	31,443)	29,161)	27,111)	30,192)	34,277)	34,343)	31,853)
Property, plant and equipment	7,373)	7,213)	7,136)	6,903)	6,845)	6,750)	6,646)	6,481)	6,355)	6,279)	6,255)	6,035)	5,970)	6,047)	6,049)	5,868)	5,795)	5,763)	5,886)	5,740)	5,777)	6,112)
Goodwill	21,776)	21,737)	21,719)	21,751)	21,732)	21,738)	21,169)	21,147)	21,163)	21,162)	21,149)	21,112)	20,446)	20,500)	20,502)	20,519)	20,529)	20,524)	20,547)	20,517)	20,578)	22,452)
Other intangible assets	21,378)	22,486)	23,307)	26,964)	29,428)	32,760)	27,072)	28,950)	31,303)	33,569)	35,859)	38,179)	37,690)	40,103)	42,527)	44,930)	48,065)	50,819)	53,243)	56,698)	59,171)	61,666)
Deferred income taxes	4,647)	3,997)	4,236)	3,609)	3,323)	2,723)	2,768)	1,514)	1,572)	1,317)	1,344)	1,329)	1,337)	1,418)	1,439)	684)	650)	793)	1,161)	913)	1,088)	605)
Marketable debt securities	346)	344)	320)	324)	357)	367)	364)	325)	—)	—)	—)	—)	—)	—)	—)	46)	143)	288)	433)	495)	523)	651)
Other non-current assets	5,934)	5,867)	6,105)	6,044)	6,071)	6,024)	5,370)	5,214)	5,022)	4,868)	4,940)	4,745)	4,728)	4,845)	5,535)	7,403)	6,454)	7,137)	7,019)	6,896)	6,596)	5,946)
Non-current assets	61,454)	61,644)	62,823)	65,595)	67,756)	70,362)	63,389)	63,631)	65,415)	67,195)	69,547)	71,400)	70,171)	72,913)	76,052)	79,450)	81,636)	85,324)	88,289)	91,259)	93,733)	97,432)
Total assets	94,676)	92,427)	92,603)	93,670)	94,646)	99,031)	95,159)	91,263)	93,489)	94,281)	96,820)	98,196)	100,357)	103,034)	109,314)	110,893)	110,797)	112,435)	118,481)	125,536)	128,076)	129,285)

The analysis of the financial data over multiple quarters reveals several key trends and patterns across liquidity, asset management, and overall asset structure.

Cash and Cash Equivalents: Cash and cash equivalents initially rose from $15,817 million in March 2020 to a peak near mid-2020 of $19,934 million, followed by a decline throughout 2021 and 2022 reaching a low near $7,514 million in March 2023. Subsequently, a partial recovery occurred, with values improving to $12,599 million by June 2025.
Marketable Debt Securities (Current): Marketable debt securities exhibited volatility with values fluctuating from $2,505 million in early 2020 down to a minimal level around $130 million in late 2022, then partially rebounding to just over $1,000 million by mid-2025, indicating changing investment or liquidity strategies.
Receivables: Receivables presented a general upward trend, increasing from $8,290 million in March 2020 to $11,415 million by June 2025, reflecting growing sales or extended credit periods.
Inventories: Inventories showed moderate variability, starting at $2,836 million in early 2020, declining through 2020 to early 2021, then gradually increasing to a peak of $3,332 million in September 2024 before slightly reducing again, suggesting inventory management adjustments.
Other Current Assets: Other current assets increased notably from around $2,405 million in early 2020 to a peak above $7,200 million in September 2023, followed by a slight decline, indicating accumulation of other short-term assets or receivables.
Total Current Assets: Current assets peaked twice, once near $34,343 million in mid-2020 and then dipping below $27,000 million in late 2022, before recovering to $33,222 million by mid-2025. This reflects fluctuations in liquidity and working capital components.
Property, Plant, and Equipment (PP&E): PP&E showed a steady and gradual increase from $6,112 million in March 2020 to $7,373 million in June 2025, supporting ongoing investments in fixed assets.
Goodwill: Goodwill remained relatively stable, fluctuating slightly near $20,500 million for much of the period, with a modest increase to about $21,776 million by mid-2025, indicating limited acquisition activity or impairment events.
Other Intangible Assets: Other intangible assets consistently trended downward from $61,666 million in early 2020 to $21,378 million by mid-2025, showing significant amortization or disposals over time.
Deferred Income Taxes: Deferred income taxes increased from around $600 million in early 2020 to over $4,600 million by mid-2025, reflecting changes in tax liabilities or timing differences increasing in magnitude.
Marketable Debt Securities (Non-current): Non-current marketable debt securities generally declined from $651 million in early 2020 to negligible or missing levels for much of the middle periods, with slight reappearances later, indicating shifts in long-term investment allocations.
Other Non-current Assets: Other non-current assets fluctuated between roughly $5,300 million and $7,400 million, without a clear trend but with some variation indicating dynamic asset management.
Total Non-current Assets: Non-current assets overall declined from $97,432 million in early 2020 to $61,454 million by mid-2025, driven primarily by reductions in intangible assets partially offset by increases in property and equipment and deferred tax assets.
Total Assets: Total assets showed a downward trajectory from $129,285 million in March 2020 to around $92,427 million in June 2025, punctuated by some quarters of modest recovery, reflecting net decreases particularly in intangible assets and liquid investments.

Overall, the data indicates a strategic focus on managing liquidity within fluctuating cash and marketable securities levels, steady investment in tangible assets, and considerable amortization of intangible assets. The decline in total assets may warrant attention regarding asset utilization and future growth potential.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Bristol-Myers Squibb Co. (NYSE:BMY)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data